Projects
Connecting metabolic syndrome and metainflammation to neuroinflammation and neurodegeneration through the PTN/RPTPβ/ζ signalling pathway (METABNEUR)
Funding period: 2022-2025
Funding Agency: Ministry of Science and Innovation (PID2021-123865OB-I00)
Principal Investigator: Pilar Ramos and Gonzalo Herradón
Molecular and epigenetic characterization and study of tetraploidies in drug-resistant epileptic patients of the temporal lobe
Funding period: 2018-2021
Funding Agency: Proyecto de Investigación en Salud Instituto de Salud Carlos III
Principal Investigator: Dr. Mª Carmen Ovejero Benito y Dr. Cristina Torres
Pharmacogenetics of Brodalumab
Funding period: 2019-2022
Funding Agency: Leo Pharma
Principal Investigator: Mª Carmen Ovejero Benito
PRIDE: Protein Identification to discriminate dementias
Funding period: 2019-2023
Funding Agency: Alzheimer Nederland
Principal Investigator: Co-PI Marta del Campo
bPRIDE: blood Proteins for early discrimination of dementia
Funding period: 2019-2023
Funding Agency: EU Joint program Neurodegenerative disease research (JPND)
Principal Investigator: Co-PI Marta del Campo (CEU external collaborator)
Discovering novel targets for Alzheimer’s disease
Funding period: 2020-2022
Funding Agency: Investigación e innovación Gobierno de España: Acciones de dinamización 'Europa Research' 2020
Principal Investigator: Marta del Campo
Discovering novel targets for Alzheimer’s disease (DisTAD)
Funding period: 2021-2023
Funding Agency: Investigación e innovación Gobierno de España: Proyecto Nacional I+D+I
Principal Investigator: Marta del Campo
The PTN/PTPRZ1 axis as regulator of neuroinflammation induced by alcohol consumption during adolescence
Funding period: 2020-2023
Funding Agency: Ministerio de Sanidad, Servicios Sociales e Igualdad (PNSD2019/015)
Principal Investigator: Gonzalo Herradón
